Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Boeing Company stock logo
BA
Boeing
$171.42
+2.5%
$186.53
$159.70
$267.54
$105.23B1.529.65 million shs1.63 million shs
Crown Holdings, Inc. stock logo
CCK
Crown
$81.42
+1.0%
$77.43
$69.61
$96.35
$9.83B0.911.20 million shs174,802 shs
Provention Bio, Inc. stock logo
PRVB
Provention Bio
$24.98
+3.1%
$24.58
$3.18
$25.00
$2.37B2.472.28 million shs9.12 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Boeing Company stock logo
BA
Boeing
0.00%-1.53%-13.35%-18.50%-19.13%
Crown Holdings, Inc. stock logo
CCK
Crown
0.00%+3.76%+1.68%-11.19%-6.05%
Provention Bio, Inc. stock logo
PRVB
Provention Bio
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Boeing Company stock logo
BA
Boeing
3.5511 of 5 stars
4.33.00.00.01.11.70.6
Crown Holdings, Inc. stock logo
CCK
Crown
4.15 of 5 stars
3.43.02.50.01.91.71.9
Provention Bio, Inc. stock logo
PRVB
Provention Bio
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Boeing Company stock logo
BA
Boeing
2.57
Moderate Buy$222.4129.75% Upside
Crown Holdings, Inc. stock logo
CCK
Crown
2.77
Moderate Buy$99.2121.85% Upside
Provention Bio, Inc. stock logo
PRVB
Provention Bio
N/AN/AN/AN/A

Current Analyst Ratings

Latest BA, CCK, and PRVB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
The Boeing Company stock logo
BA
Boeing
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$252.00 ➝ $224.00
4/25/2024
The Boeing Company stock logo
BA
Boeing
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$240.00 ➝ $225.00
4/22/2024
The Boeing Company stock logo
BA
Boeing
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$235.00 ➝ $190.00
4/17/2024
The Boeing Company stock logo
BA
Boeing
Northcoast Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Sell$140.00
4/16/2024
The Boeing Company stock logo
BA
Boeing
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$225.00 ➝ $215.00
4/16/2024
Crown Holdings, Inc. stock logo
CCK
Crown
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$85.00 ➝ $90.00
4/12/2024
The Boeing Company stock logo
BA
Boeing
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$230.00 ➝ $210.00
4/11/2024
The Boeing Company stock logo
BA
Boeing
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$210.00 ➝ $190.00
4/11/2024
Crown Holdings, Inc. stock logo
CCK
Crown
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$78.00 ➝ $76.00
4/10/2024
The Boeing Company stock logo
BA
Boeing
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$270.00 ➝ $260.00
4/10/2024
The Boeing Company stock logo
BA
Boeing
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$235.00 ➝ $180.00
(Data available from 4/29/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Boeing Company stock logo
BA
Boeing
$77.79B1.35N/AN/A($28.24) per share-6.07
Crown Holdings, Inc. stock logo
CCK
Crown
$12.01B0.82$10.05 per share8.10$23.74 per share3.43
Provention Bio, Inc. stock logo
PRVB
Provention Bio
$12.90M183.54N/AN/A$1.40 per share17.84

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Boeing Company stock logo
BA
Boeing
-$2.22B-$3.55N/A29.81N/A-2.81%N/A-2.55%7/24/2024 (Estimated)
Crown Holdings, Inc. stock logo
CCK
Crown
$450M$3.7621.6512.392.733.75%25.75%4.81%4/29/2024 (Confirmed)
Provention Bio, Inc. stock logo
PRVB
Provention Bio
-$113.57M-$1.53N/AN/AN/A-880.69%-103.36%-69.08%N/A

Latest BA, CCK, and PRVB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/29/2024N/A
Crown Holdings, Inc. stock logo
CCK
Crown
$0.96N/A-$0.96N/AN/AN/A  
2/6/202412/31/2023
Crown Holdings, Inc. stock logo
CCK
Crown
$1.43$1.24-$0.19$2.21$2.96 billion$2.86 billion    
1/31/2024Q4 2023
The Boeing Company stock logo
BA
Boeing
-$0.72-$0.47+$0.25-$0.90$21.14 billion$22.02 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Boeing Company stock logo
BA
Boeing
N/AN/AN/AN/AN/A
Crown Holdings, Inc. stock logo
CCK
Crown
$1.001.23%N/A26.60%3 Years
Provention Bio, Inc. stock logo
PRVB
Provention Bio
N/AN/AN/AN/AN/A

Latest BA, CCK, and PRVB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/22/2024
Crown Holdings, Inc. stock logo
CCK
Crown
quarterly$0.251.3%3/13/20243/14/20243/28/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Boeing Company stock logo
BA
Boeing
N/A
1.14
0.25
Crown Holdings, Inc. stock logo
CCK
Crown
2.34
1.15
0.77
Provention Bio, Inc. stock logo
PRVB
Provention Bio
0.19
1.93
1.92

Ownership

Institutional Ownership

CompanyInstitutional Ownership
The Boeing Company stock logo
BA
Boeing
64.82%
Crown Holdings, Inc. stock logo
CCK
Crown
90.93%
Provention Bio, Inc. stock logo
PRVB
Provention Bio
37.39%

Insider Ownership

CompanyInsider Ownership
The Boeing Company stock logo
BA
Boeing
0.16%
Crown Holdings, Inc. stock logo
CCK
Crown
0.90%
Provention Bio, Inc. stock logo
PRVB
Provention Bio
13.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
The Boeing Company stock logo
BA
Boeing
171,000613.88 million612.90 millionOptionable
Crown Holdings, Inc. stock logo
CCK
Crown
25,000120.79 million119.71 millionOptionable
Provention Bio, Inc. stock logo
PRVB
Provention Bio
8294.78 million82.37 millionNot Optionable

BA, CCK, and PRVB Headlines

SourceHeadline
Macrogenics Inc MGNXMacrogenics Inc MGNX
morningstar.com - December 29 at 11:00 PM
And for Wegovys Next Trick, Full-Blown Cardiovascular Benefit Outside DiabetesAnd for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetes
medpagetoday.com - November 13 at 5:48 PM
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 DiabetesTeplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes
nejm.org - October 24 at 9:51 AM
FDA sets August decision date for Proventions type 1 diabetes drugFDA sets August decision date for Provention's type 1 diabetes drug
pharmaphorum.com - July 23 at 5:52 PM
Larry Pine Biography & MoviesLarry Pine Biography & Movies
tribute.ca - June 27 at 3:22 PM
Sanofi/Provention: innovative diabetes drug is a good fitSanofi/Provention: innovative diabetes drug is a good fit
finance.yahoo.com - May 1 at 10:47 AM
Those who invested in Provention Bio (NASDAQ:PRVB) a year ago are up 456%Those who invested in Provention Bio (NASDAQ:PRVB) a year ago are up 456%
finance.yahoo.com - April 29 at 9:55 AM
Sanofi completes Provention Bio acquisitionSanofi completes Provention Bio acquisition
seekingalpha.com - April 28 at 9:22 AM
Sanofi concludes acquisition of Provention BioSanofi concludes acquisition of Provention Bio
medicaldialogues.in - April 28 at 4:06 AM
Sanofi completes acquisition of Provention Bio, Inc.Sanofi completes acquisition of Provention Bio, Inc.
pharmiweb.com - April 28 at 4:06 AM
Earnings Preview: Provention Bio, Inc. (PRVB) Q1 Earnings Expected to DeclineEarnings Preview: Provention Bio, Inc. (PRVB) Q1 Earnings Expected to Decline
finance.yahoo.com - April 27 at 1:01 PM
Sanofi - Aventis Groupe: Press Release: Hart-Scott-Rodino waiting period expires for Sanofis acquisition of Provention Bio, Inc.Sanofi - Aventis Groupe: Press Release: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Provention Bio, Inc.
finanznachrichten.de - April 27 at 2:00 AM
Provention Bio gains after HSR waiting period for Sanofi deal expiredProvention Bio gains after HSR waiting period for Sanofi deal expired
seekingalpha.com - April 26 at 3:59 PM
Press Release: Hart-Scott-Rodino waiting period expires for Sanofis acquisition of Provention Bio, Inc.Press Release: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Provention Bio, Inc.
benzinga.com - April 26 at 10:51 AM
Sanofi’s $2.9 Billion Provention Bio Deal Draws Investor LawsuitSanofi’s $2.9 Billion Provention Bio Deal Draws Investor Lawsuit
news.bloomberglaw.com - April 25 at 11:24 PM
PRVB Apr 2023 23.000 putPRVB Apr 2023 23.000 put
finance.yahoo.com - April 22 at 10:13 AM
Sanofis $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More InformationSanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information
msn.com - April 11 at 3:59 PM
Provention Bio, Inc. (NASDAQ:PRVB) Just Reported And Analysts Have Been Cutting Their EstimatesProvention Bio, Inc. (NASDAQ:PRVB) Just Reported And Analysts Have Been Cutting Their Estimates
finance.yahoo.com - April 2 at 10:41 AM
Gaithersburg’s Novavax locks in consulting deal with outgoing R&D headGaithersburg’s Novavax locks in consulting deal with outgoing R&D head
bizjournals.com - March 27 at 7:11 PM
(PRVB): Johnson Fistel Investigates Proposed Sale of Provention Bio Inc.; Is $25.00 a Fair Price?(PRVB): Johnson Fistel Investigates Proposed Sale of Provention Bio Inc.; Is $25.00 a Fair Price?
benzinga.com - March 17 at 7:02 PM
Q4 2022 MacroGenics Inc Earnings CallQ4 2022 MacroGenics Inc Earnings Call
finance.yahoo.com - March 16 at 9:12 AM
Provention Bios Earnings OutlookProvention Bio's Earnings Outlook
benzinga.com - March 15 at 2:10 PM
SMBC Nikko Downgrades Provention Bio (PRVB)SMBC Nikko Downgrades Provention Bio (PRVB)
msn.com - March 14 at 10:52 PM
Jefferies Downgrades Provention Bio (PRVB)Jefferies Downgrades Provention Bio (PRVB)
msn.com - March 14 at 10:52 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Boeing logo

Boeing

NYSE:BA
The Boeing Company, together with its subsidiaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight and launch systems, and services worldwide. The company operates through Commercial Airplanes; Defense, Space & Security; and Global Services segments. The Commercial Airplanes segment develops, produces, and markets commercial jet aircraft for passenger and cargo requirements, as well as provides fleet support services. The Defense, Space & Security segment engages in the research, development, production, and modification of manned and unmanned military aircraft and weapons systems; strategic defense and intelligence systems, which include strategic missile and defense systems, command, control, communications, computers, intelligence, surveillance and reconnaissance, cyber and information solutions, and intelligence systems; and satellite systems, such as government and commercial satellites, and space exploration. The Global Services segment offers products and services, including supply chain and logistics management, engineering, maintenance and modifications, upgrades and conversions, spare parts, pilot and maintenance training systems and services, technical and maintenance documents, and data analytics and digital services to commercial and defense customers. The Boeing Company was incorporated in 1916 and is based in Arlington, Virginia.
Crown logo

Crown

NYSE:CCK
Crown Holdings, Inc., together with its subsidiaries, engages in the packaging business in the United States and internationally. It operates through Americas Beverage, European Beverage, Asia Pacific, and Transit Packaging segments. The company manufactures and sells recyclable aluminum beverage cans and ends, glass bottles, steel crowns, aluminum caps, non-beverage cans, and aerosol cans and closures. It also provides manual, semi-automatic, and automatic equipment and tools to apply and remove consumables, such as straps and films; protective solutions, including airbags, edge protectors, and honeycomb products; and steel and plastic consumables include steel strap, plastic strap, industrial film, and other related products. The company serves food industries, including pet food, personal care, household, and industrial products. Crown Holdings, Inc. was founded in 1892 and is headquartered in Yardley, Pennsylvania.
Provention Bio logo

Provention Bio

NASDAQ:PRVB
Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn's disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ.